Pharmatech, Inc. Continues Record Growth in 2015
DENVER, Colo., Feb. 9, 2015 /PRNewswire/ -- Pharmatech, Inc. continues record growth into 2015. The specialized oncology CRO/SMO sets another record year – 38% annualized growth rate over the last 3 years.
The company sets its sights on even more aggressive targets into 2015 and beyond. The company's increase in growth will be fueled by its AccessPPM program and expanded CRO capabilities to meet the challenges associated with the cancer studies of tomorrow. In 2012, the company received an NCI supported grant to "rethink" how cancer clinical trials are managed and developed AccessPPM – a cancer patient registry that matched cancer patients to clinical trials by disease and genetic mutations. A sizable position of industry trials are focused toward genetic abnormalities and there isn't necessarily a connecting point for cancer patients until now.
In 2014, Pharmatech inked strategic deals with global CRO's and became a partners to 3 out of the top 10 largest pharmaceutical companies. Led by CEO, Rob Bohacs, the companies continues to gain momentum as a niche oncology CRO. "We have quite a bit of work ahead of us into 2015 and excited about the opportunities in the marketplace, including the opportunity to further expand our service offerings through organic growth and acquisition. We also will commence the commercialization of our AccessPPM datasets as we begin to assess patient outcome survival data with genetic information" according to Rob Bohacs. The company is also making some significant announcement in the first half of 2015.
About Pharmatech, Inc.
Pharmatech, Inc. is an oncology Contract Research Organization (CRO) that specializes in creating efficiencies in the clinical trial process. Through an organized network of cancer clinics, the company focuses on advancing the development of products for a broad range of pharmaceutical and biotechnology companies, and on promoting the inclusion of clinical trials in the spectrum of patient treatment options.
For more information about Pharmatech, please visit: http://www.pharmatech.com or contact us at [email protected]
SOURCE Pharmatech, Inc.
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article